Contract 75A50120C00092
Phlow Corp. · Department Of Health And Human Services · May 18, 2020
Phlow Corp. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on May 18, 2020 for $696.67 million of work in pharmaceutical preparation manufacturing. Performance is in Richmond, VA. It was awarded under full and open competition. The contract has been modified 30 times since the base award It uses cost-plus contract pricing. The most recent modification was on March 3, 2026.
Contract details
- PIID
- 75A50120C00092
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- R&D- Medical: Biomedical (Commercialized)
- Place of performance
- Richmond, VA
- First action
- May 18, 2020
- Latest action
- March 3, 2026
Description
THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0022 FROM MARCH 3, 2026 TO MAY 3, 2026
Modification timeline
-
March 3, 2026Mod P00030$0
-
February 19, 2026Mod P00029THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0025 FROM FEB 25, 2026 TO APRIL 25, 2026$0
-
January 30, 2026Mod P00028THE PURPOSE OF THIS ACTION IS TO EXTEND CLIN 0008 AT NO ADDITIONAL COST TO THE GOVERNMENT$0
-
January 26, 2026Mod P00026THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE$26.37M
-
January 26, 2026Mod P00027THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE$53.90M
-
January 5, 2026Mod P00025THE PURPOSE OF MODIFICATION P00020 IS TO EXERCISE OPTION CLIN 0010 AND INCORPORATE CHANGES TO THE DESCRIPTION OF SERVICES FOR DOMESTIC PRODUCIBILITY OF ESSENTIA$0
-
December 12, 2025Mod P00024COR CHANGE$0
-
December 1, 2025Mod P00023ADD CLAUSE FAR 52.232-16 PROGRESS PAYMENTS (NOV 2021) ALTERNATE I (MAR 2000)$0
-
November 4, 2025Mod P00022REVISE THE SCOPE OF EFFORT$25.00M
-
October 23, 2025Mod P00021UPDATE POC INFORMATION$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120C00092?
Contract 75A50120C00092 is a federal contract awarded to Phlow Corp. by Department Of Health And Human Services on May 18, 2020 for $696.67 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 30 times since the base award.
Who won contract 75A50120C00092?
Phlow Corp. won contract 75A50120C00092 from Department Of Health And Human Services.
How much is contract 75A50120C00092 worth?
Contract 75A50120C00092 has obligated $696.67 million to date, with a total potential value of $969.75 million if all options are exercised.